Sign up to save your podcasts
Or
Share Season 4: Episode 5 - Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Season 4: Episode 5 - Key Considerations for Comparative Quality Studies for the Proposed Biosimilar Product in EU
In the last episode of Freyr Regulatory Radio, Season 4, our experts discuss key considerations for Comparative Quality Studies for a proposed biosimilar product in the EU.
Furthermore, this episode throws light upon the criteria for the reference biological products and its evaluation.
To know more about Season 4, visit: https://www.freyrsolutions.com/regulatory-radio/season-4-eu-regulatory-pathways-for-biological-products
View all episodes
By Freyr SolutionsIn the last episode of Freyr Regulatory Radio, Season 4, our experts discuss key considerations for Comparative Quality Studies for a proposed biosimilar product in the EU.
Furthermore, this episode throws light upon the criteria for the reference biological products and its evaluation.
To know more about Season 4, visit: https://www.freyrsolutions.com/regulatory-radio/season-4-eu-regulatory-pathways-for-biological-products